EC Paediatrics

Research Article Volume 13 Issue 1 - 2024

Inhaled Budesonide Versus Fluticasone Propionate in Managing Asthma in Children: A Randomized, Open-Label, Parallel-Group Trial

Sushant Mane1,2, Snehal Sonune1,2, Manas Pustake1,2*, Sakina Rajagara1,2 and Anindita Mandal1,2

1Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India
2Centre of Excellence for Pediatric TB, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India

*Corresponding Author: Sushant Mane, Department of Pediatrics, Grant Government Medical College and Sir JJ Group of Hospitals, and Centre of Excellence for Pediatric TB, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India.
Received: December 05, 2023;; Published: December 29, 2023



This study investigates the comparative effectiveness of inhaled Budesonide (BUD) and Fluticasone Propionate (FP) in the management of childhood asthma. Asthma, a chronic inflammatory disease of the airways, is a significant cause of morbidity in children, characterized by episodes of airflow obstruction and hyperresponsiveness. The study aims to compare the peak expiratory flow (PEF), FEV1, FEV1/FVC ratios, response to therapy, and side effects between children treated with Budesonide and Fluticasone Propionate.

Conducted over 18 months at a single tertiary care hospital, this single-center, single-blind, randomized controlled study included 90 newly diagnosed pediatric asthma patients. They were equally divided into two groups: Group A receiving Budesonide and Group B receiving Fluticasone Propionate. The study utilized a 4 block randomization method to ensure equal distribution and blinding of patients to the treatment received.

The results of this study are anticipated to provide valuable insights into the efficacy and safety profiles of Budesonide and Fluticasone Propionate in pediatric asthma management, potentially guiding clinical decision-making and optimizing patient outcomes. The study's findings are particularly relevant given the lack of comparative studies in this area, especially in the Indian context.

 Keywords: Budesonide; Fluticasone Propionate; Children; Asthma